These findings, together with the high CD155 expression in advanced clinical stage of human malignancies including melanoma, glioblastoma, pancreatic, colon and lung cancers [16,17,18,19,20,21], support a role for CD155 as pro-tumorigenic molecule. This evidence concerns the gene PVR and lung cancer.